News
Clinical trial data review on weight-loss drugs reveals weight regain patterns post-medication discontinuation, impacting weight management strategies.
2h
HealthDay on MSNRisk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, ObesityFor adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
A WOMAN who lost a staggering five stone thanks to weight-loss jabs has hit back at trolls who brand her an “Ozempic cheat”.
Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.
Drugs like Ozempic and Mounjaro are becoming increasingly popular for treating obesity and type 2 diabetes. These medications ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
A TikTokker has lifted the lid on an “unwanted” and “not talked about” side effect of the weight loss drug Mounjaro. Mounjaro, a diabetic medicine which also is used as a weight loss aid now, is ...
The Mounjaro buzz is now distinctly reaching Indian A-listers and wellness-conscious urban adults, sparking conversations about its potential ...
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results